Understanding the role of the NMDA receptor subunit, GluN2D, in mediating NMDA receptor antagonist‐induced behavioral disruptions in male and female mice
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Understanding the role of the NMDA receptor subunit, GluN2D, in mediating NMDA receptor antagonist‐induced behavioral disruptions in male and female mice
Authors
Keywords
-
Journal
JOURNAL OF NEUROSCIENCE RESEARCH
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2023-10-12
DOI
10.1002/jnr.25257
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- (R)-ketamine attenuates neurodevelopmental disease-related phenotypes in a mouse model of maternal immune activation
- (2023) Elifrances Galdino de Oliveira et al. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
- Synaptic Variability and Cortical Gamma Oscillation Power in Schizophrenia
- (2022) Daniel W. Chung et al. AMERICAN JOURNAL OF PSYCHIATRY
- Is (R)-ketamine a potential therapeutic agent for treatment-resistant depression with less detrimental side effects? A review of molecular mechanisms underlying ketamine and its enantiomers
- (2022) Ellen Scotton et al. BIOCHEMICAL PHARMACOLOGY
- Sirtuin Type 1 Mediates the Antidepressant Effect of S-Ketamine in a Chronic Unpredictable Stress Model
- (2022) Lanwei Hou et al. Frontiers in Psychiatry
- Mu opioid receptor activation mediates (S)-ketamine reinforcement in rats: implications for abuse liability
- (2022) Marjorie R. Levinstein et al. BIOLOGICAL PSYCHIATRY
- Repurposing Cholinesterase Inhibitors as Antidepressants? Dose and Stress-Sensitivity May Be Critical to Opening Possibilities
- (2021) Paul J. Fitzgerald et al. Frontiers in Behavioral Neuroscience
- Pharmacological and behavioral divergence of ketamine enantiomers: implications for abuse liability
- (2021) Jordi Bonaventura et al. MOLECULAR PSYCHIATRY
- The effect of esketamine in patients with treatment‐resistant depression with and without comorbid anxiety symptoms or disorder
- (2021) Ella J. Daly et al. DEPRESSION AND ANXIETY
- Structural basis of ketamine action on human NMDA receptors
- (2021) Youyi Zhang et al. NATURE
- Effect of Neonatal Treatment With the NMDA Receptor Antagonist, MK-801, During Different Temporal Windows of Postnatal Period in Adult Prefrontal Cortical and Hippocampal Function
- (2021) Maria E. Plataki et al. Frontiers in Behavioral Neuroscience
- The effectiveness of (R)-ketamine and its mechanism of action differ from those of (S)-ketamine in a chronic unpredictable mild stress model of depression in C57BL/6J mice
- (2021) Anna Rafało-Ulińska et al. BEHAVIOURAL BRAIN RESEARCH
- Intravenous arketamine for treatment-resistant depression: open-label pilot study
- (2020) Gustavo C. Leal et al. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
- Marble-burying behavior test as a murine model of compulsive-like behavior
- (2020) Pankaj Vinod Dixit et al. JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS
- BNST GluN2D-Containing NMDA Receptors Influence Anxiety- and Depressive-like Behaviors and ModulateCell-Specific Excitatory/Inhibitory Synaptic Balance
- (2020) Gregory J. Salimando et al. JOURNAL OF NEUROSCIENCE
- Reproducing the dopamine pathophysiology of schizophrenia and approaches to ameliorate it: a translational imaging study with ketamine
- (2020) Michelle Kokkinou et al. MOLECULAR PSYCHIATRY
- GluN2D-mediated excitatory drive onto medial prefrontal cortical PV+ fast-spiking inhibitory interneurons
- (2020) Jonathan Garst-Orozco et al. PLoS One
- Meta-Analysis of Sensorimotor Gating Deficits in Patients With Schizophrenia Evaluated by Prepulse Inhibition Test
- (2020) Rodrigo San-Martin et al. SCHIZOPHRENIA BULLETIN
- Parvalbumin and Somatostatin Interneurons Contribute to the Generation of Hippocampal Gamma Oscillations
- (2020) Pantelis Antonoudiou et al. JOURNAL OF NEUROSCIENCE
- Phencyclidine-induced cognitive impairments in repeated touchscreen visual reversal learning tests in rats
- (2020) Katja Savolainen et al. BEHAVIOURAL BRAIN RESEARCH
- Ketamine activated glutamatergic neurotransmission by GABAergic disinhibition in the medial prefrontal cortex
- (2020) Bing Zhang et al. NEUROPHARMACOLOGY
- Tonic activation of GluN2C/GluN2D-containing NMDA receptors by ambient glutamate facilitates cortical interneuron maturation
- (2019) Elizabeth Hanson et al. JOURNAL OF NEUROSCIENCE
- Sex-specific spatial memory deficits in mice with a conditional TrkB deletion on parvalbumin interneurons
- (2019) Adrienne Mary Grech et al. BEHAVIOURAL BRAIN RESEARCH
- Cognitive impairment that is induced by (R)-ketamine is abolished in NMDA GluN2D receptor subunit knockout mice
- (2019) Soichiro Ide et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Comparison of antidepressant and side effects in mice after intranasal administration of (R,S)-ketamine, (R)-ketamine, and (S)-ketamine
- (2019) Lijia Chang et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Differential effect of NMDA receptor GluN2C and GluN2D subunit ablation on behavior and channel blocker-induced schizophrenia phenotypes
- (2019) Gajanan P. Shelkar et al. Scientific Reports
- Attenuation of antidepressant and antisuicidal effects of ketamine by opioid receptor antagonism
- (2019) Nolan R. Williams et al. MOLECULAR PSYCHIATRY
- Pre-frontal parvalbumin interneurons in schizophrenia: a meta-analysis of post-mortem studies
- (2019) Stephen J. Kaar et al. JOURNAL OF NEURAL TRANSMISSION
- Synaptic biomarker reduction and impaired cognition in the sub-chronic PCP mouse model for schizophrenia
- (2019) John Gigg et al. JOURNAL OF PSYCHOPHARMACOLOGY
- The origin of NMDA receptor hypofunction in schizophrenia
- (2019) Kazu Nakazawa et al. PHARMACOLOGY & THERAPEUTICS
- Meningeal γδ T cell–derived IL-17 controls synaptic plasticity and short-term memory
- (2019) Miguel Ribeiro et al. Science Immunology
- NMDA receptors on parvalbumin-positive interneurons and pyramidal neurons both contribute to MK-801 induced gamma oscillatory disturbances: Complex relationships with behaviour
- (2019) Matthew R. Hudson et al. NEUROBIOLOGY OF DISEASE
- Phencyclidine-induced cognitive deficits in mice are ameliorated by subsequent repeated intermittent administration of (R)-ketamine, but not (S)-ketamine: Role of BDNF-TrkB signaling
- (2019) Yunfei Tan et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Efficacy and Safety of Intranasal Esketamine for the Rapid Reduction of Symptoms of Depression and Suicidality in Patients at Imminent Risk for Suicide: Results of a Double-Blind, Randomized, Placebo-Controlled Study
- (2018) Carla M. Canuso et al. AMERICAN JOURNAL OF PSYCHIATRY
- The role of N-methyl-D-aspartate receptors and metabotropic glutamate receptor 5 in the prepulse inhibition paradigms for studying schizophrenia
- (2018) Zhemeng Wu et al. BEHAVIOURAL PHARMACOLOGY
- Anxiolytic effects of ascorbic acid and ketamine in mice
- (2018) Daiane B. Fraga et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Alterations in cortical interneurons and cognitive function in schizophrenia
- (2018) Samuel J. Dienel et al. NEUROBIOLOGY OF DISEASE
- In the Telencephalon, GluN2C NMDA Receptor Subunit mRNA is Predominately Expressed in Glial Cells and GluN2D mRNA in Interneurons
- (2018) Hassan A. Alsaad et al. NEUROCHEMICAL RESEARCH
- Disinhibition of CA1 pyramidal cells by low-dose ketamine and other antagonists with rapid antidepressant efficacy
- (2018) Allie J. Widman et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Attenuation of Antidepressant Effects of Ketamine by Opioid Receptor Antagonism
- (2018) Nolan R. Williams et al. AMERICAN JOURNAL OF PSYCHIATRY
- Similar psychotic and cognitive profile between ketamine dependence with persistent psychosis and schizophrenia
- (2018) Wan-Ju Cheng et al. SCHIZOPHRENIA RESEARCH
- Antidepressant Potential of ( R )-Ketamine in Rodent Models: Comparison with ( S )-Ketamine
- (2017) Kenichi Fukumoto et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Transcriptome alterations of prefrontal cortical parvalbumin neurons in schizophrenia
- (2017) J F Enwright III et al. MOLECULAR PSYCHIATRY
- NMDA receptor antagonist rodent models for cognition in schizophrenia and identification of novel drug treatments, an update
- (2017) Daniela Cadinu et al. NEUROPHARMACOLOGY
- Loss of GluN2D subunit results in social recognition deficit, social stress, 5-HT2C receptor dysfunction, and anhedonia in mice
- (2017) Hideko Yamamoto et al. NEUROPHARMACOLOGY
- Schizophrenia is associated with a pattern of spatial working memory deficits consistent with cortical disinhibition
- (2017) Martina Starc et al. SCHIZOPHRENIA RESEARCH
- Towards the development of improved tests for negative symptoms of schizophrenia in a validated animal model
- (2016) Ceren Sahin et al. BEHAVIOURAL BRAIN RESEARCH
- Intravenous Esketamine in Adult Treatment-Resistant Depression: A Double-Blind, Double-Randomization, Placebo-Controlled Study
- (2016) Jaskaran B. Singh et al. BIOLOGICAL PSYCHIATRY
- Reduced Labeling of Parvalbumin Neurons and Perineuronal Nets in the Dorsolateral Prefrontal Cortex of Subjects with Schizophrenia
- (2016) John F Enwright et al. NEUROPSYCHOPHARMACOLOGY
- Sex/gender differences in the brain and cognition in schizophrenia
- (2016) Adrianna Mendrek et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Role of the NMDA receptor GluN2D subunit in the expression of ketamine-induced behavioral sensitization and region-specific activation of neuronal nitric oxide synthase
- (2016) Toshifumi Yamamoto et al. NEUROSCIENCE LETTERS
- Loss of parvalbumin-immunoreactivity in mouse brain regions after repeated intermittent administration of esketamine, but not R-ketamine
- (2016) Chun Yang et al. PSYCHIATRY RESEARCH
- The novel ketamine analog methoxetamine produces dissociative-like behavioral effects in rodents
- (2016) Adam L. Halberstadt et al. PSYCHOPHARMACOLOGY
- Alterations in Cortical Network Oscillations and Parvalbumin Neurons in Schizophrenia
- (2015) Guillermo Gonzalez-Burgos et al. BIOLOGICAL PSYCHIATRY
- Preliminary analysis of positive and negative syndrome scale in ketamine-associated psychosis in comparison with schizophrenia
- (2015) Ke Xu et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Sex differences in glutamate receptor gene expression in major depression and suicide
- (2015) A L Gray et al. MOLECULAR PSYCHIATRY
- The impact of NMDA receptor hypofunction on GABAergic neurons in the pathophysiology of schizophrenia
- (2015) Samuel M. Cohen et al. SCHIZOPHRENIA RESEARCH
- GluN2D-containing NMDA receptors-mediate synaptic currents in hippocampal interneurons and pyramidal cells in juvenile mice
- (2015) Jakob von Engelhardt et al. Frontiers in Cellular Neuroscience
- R-ketamine: a rapid-onset and sustained antidepressant without psychotomimetic side effects
- (2015) C Yang et al. Translational Psychiatry
- Sensorimotor gating impairments induced by MK-801 treatment may be reduced by tolerance effect and by familiarization in monkeys
- (2015) Patricia G. Saletti et al. Frontiers in Pharmacology
- Crystal structure of a heterotetrameric NMDA receptor ion channel
- (2014) E. Karakas et al. SCIENCE
- GABA level, gamma oscillation, and working memory performance in schizophrenia
- (2014) Chi-Ming A. Chen et al. NeuroImage-Clinical
- Ketamine increases striatal dopamine release and hyperlocomotion in adult rats after postnatal functional blockade of the prefrontal cortex
- (2013) Y. Usun et al. BEHAVIOURAL BRAIN RESEARCH
- GluN2C/GluN2D subunit-selective NMDA receptor potentiator CIQ reverses MK-801-induced impairment in prepulse inhibition and working memory in Y-maze test in mice
- (2013) P S Suryavanshi et al. BRITISH JOURNAL OF PHARMACOLOGY
- Acute and chronic effects of NMDA receptor antagonists in rodents, relevance to negative symptoms of schizophrenia: A translational link to humans
- (2013) Joanna C. Neill et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- NMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and disease
- (2013) Pierre Paoletti et al. NATURE REVIEWS NEUROSCIENCE
- Influence of GluN2 subunit identity on NMDA receptor function
- (2013) D.J.A. Wyllie et al. NEUROPHARMACOLOGY
- The Impact of NMDA Receptor Blockade on Human Working Memory-Related Prefrontal Function and Connectivity
- (2013) Naomi R Driesen et al. NEUROPSYCHOPHARMACOLOGY
- R (−)-ketamine shows greater potency and longer lasting antidepressant effects than S (+)-ketamine
- (2013) Ji-chun Zhang et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Are Sexes Affected Differently by Ketamine? An Exploratory Study in Ketamine Users
- (2013) Hua Jun Liang et al. SUBSTANCE USE & MISUSE
- Involvement of the N-methyl-d-aspartate receptor GluN2D subunit in phencyclidine-induced motor impairment, gene expression, and increased Fos immunoreactivity
- (2013) Hideko Yamamoto et al. Molecular Brain
- Long-term behavioral and NMDA receptor effects of young-adult corticosterone treatment in BDNF heterozygous mice
- (2012) Maren Klug et al. NEUROBIOLOGY OF DISEASE
- Altered N-methyl-d-aspartate receptor function in reelin heterozygous mice: Male–female differences and comparison with dopaminergic activity
- (2012) Maarten van den Buuse et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- The effects of phencyclidine (PCP) on anxiety-like behavior in the elevated plus maze and the light–dark exploration test are age dependent, sexually dimorphic, and task dependent
- (2011) Sarah M. Turgeon et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Taming the Ketamine Tiger
- (2010) Edward F. Domino ANESTHESIOLOGY
- Glutamate Receptor Ion Channels: Structure, Regulation, and Function
- (2010) S. F. Traynelis et al. PHARMACOLOGICAL REVIEWS
- Essential Role of NMDA Receptor Channel ε4 Subunit (GluN2D) in the Effects of Phencyclidine, but Not Methamphetamine
- (2010) Yoko Hagino et al. PLoS One
- Marble burying reflects a repetitive and perseverative behavior more than novelty-induced anxiety
- (2009) Alexia Thomas et al. PSYCHOPHARMACOLOGY
- Dopamine D2Highreceptors stimulated by phencyclidines, lysergic acid diethylamide, salvinorin A, and modafinil
- (2009) Philip Seeman et al. SYNAPSE
- Effects of subchronic phencyclidine (PCP) treatment on social behaviors and operant discrimination and reversal learning in C57BL/6J mice
- (2009) Jonathan L. Brigman Frontiers in Behavioral Neuroscience
- Developmental Regulation of the NMDA Receptor Subunits, NR3A and NR1, in Human Prefrontal Cortex
- (2008) Maile A. Henson et al. CEREBRAL CORTEX
- Cataleptic effects of γ-hydroxybutyrate (GHB) and baclofen in mice: mediation by GABAB receptors, but differential enhancement by N-methyl-d-aspartate (NMDA) receptor antagonists
- (2008) Wouter Koek et al. PSYCHOPHARMACOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now